Arcturus Therapeutics Holdings Inc.
For the period ended Dec 31, 2025. Filed Mar 3, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 3, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits, Financial Statement Schedules
(a)
(1) The information required by this item is included in Item 8 of Part II of this Annual Report.;
(2) Financial statement schedules not listed above have been omitted because information required to be set forth therein is not applicable, not required, or the information required by such schedules is shown in the consolidated financial statements or the notes thereto.
(3) See the exhibit index preceding the signature pages to this Annual Report, which is incorporated by reference herein.
(b) See the exhibit index preceding the signature pages to this Annual Report, which is incorporated by reference herein.
(c) Not applicable.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.